Director Ownership Update for InMed Pharmaceuticals Inc.

Neil A. Klompas, a director of InMed Pharmaceuticals Inc., has reported no securities owned as of October 9, 2024. The filing, submitted on October 17, 2025, indicates that Klompas holds no shares in the company. This Form 3 filing is a routine disclosure required by the SEC for directors and officers to report their ownership stakes in the company. The lack of securities owned by Klompas does not indicate any significant change in the company's ownership structure but is a standard regulatory requirement.